|
RELATED PARTY TRANSACTIONS
|
6 Months Ended |
|---|---|
|
Jun. 30, 2013
|
|
| Related Party Transactions [Abstract] | |
| Related Party Transactions Disclosure [Text Block] | 8. RELATED PARTY TRANSACTIONS
Jamey Weichert, the Company’s Chief Scientific Officer and principal founder of Cellectar, and a director and shareholder of the Company, is a faculty member at the University of Wisconsin-Madison (“UW”). During the three and six months ended June 30, 2013, the Company made contributions to UW totaling $62,500 and $125,000, respectively for use towards unrestricted research activities. The Company paid $73,385 to UW for costs associated with clinical trial and other research agreements during both the three and six months ended June 30, 2013. The Company made contributions to UW of $62,500 and $144,000 for use towards unrestricted research activities during the three and six months ended June 30, 2012, respectively and paid UW $51,290 and $144,044 for costs associated with clinical trial agreements during the three and six months ended June 30, 2012, respectively. |